Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.

Maurel M, Howard J, Kissling E, Pozo F, Pérez-Gimeno G, Buda S, Sève N, McKenna A, Meijer A, Rodrigues AP, Martínez-Baz I, Mlinarić I, Latorre-Margalef N, Túri G, Lazăr M, Mazagatos C, Echeverria A, Abela S, Bourgeois M, Machado A, Dürrwald R, Petrović G, Oroszi B, Jancoriene L, Marin A, Husa P, Duffy R, Dijkstra F, Gallardo García V, Goerlitz L, Enouf V, Bennett C, Hooiveld M, Guiomar R, Trobajo-Sanmartín C, Višekruna Vučina V, Samuelsson Hagey T, Lameiras Azevedo AS, Castilla J, Xuereb G, Delaere B, Gómez V, Tolksdorf K, Bacci S, Nicolay N, Kaczmarek M, Rose AM, European IVE group

Open source

DOI: 10.2807/1560-7917.es.2024.29.8.2400089
Published: 2024 Feb
Container: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2807/1560-7917.es.2024.29.8.2400089,
  title = {Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.},
  author = {Maurel M and Howard J and Kissling E and Pozo F and Pérez-Gimeno G and Buda S and Sève N and McKenna A and Meijer A and Rodrigues AP and Martínez-Baz I and Mlinarić I and Latorre-Margalef N and Túri G and Lazăr M and Mazagatos C and Echeverria A and Abela S and Bourgeois M and Machado A and Dürrwald R and Petrović G and Oroszi B and Jancoriene L and Marin A and Husa P and Duffy R and Dijkstra F and Gallardo García V and Goerlitz L and Enouf V and Bennett C and Hooiveld M and Guiomar R and Trobajo-Sanmartín C and Višekruna Vučina V and Samuelsson Hagey T and Lameiras Azevedo AS and Castilla J and Xuereb G and Delaere B and Gómez V and Tolksdorf K and Bacci S and Nicolay N and Kaczmarek M and Rose AM and European IVE group},
  year = {2024},
  journal = {Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin},
  doi = {10.2807/1560-7917.es.2024.29.8.2400089},
  url = {https://doi.org/10.2807/1560-7917.es.2024.29.8.2400089}
}

RIS

TY  - JOUR
TI  - Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
AU  - Maurel M
AU  - Howard J
AU  - Kissling E
AU  - Pozo F
AU  - Pérez-Gimeno G
AU  - Buda S
AU  - Sève N
AU  - McKenna A
AU  - Meijer A
AU  - Rodrigues AP
AU  - Martínez-Baz I
AU  - Mlinarić I
AU  - Latorre-Margalef N
AU  - Túri G
AU  - Lazăr M
AU  - Mazagatos C
AU  - Echeverria A
AU  - Abela S
AU  - Bourgeois M
AU  - Machado A
AU  - Dürrwald R
AU  - Petrović G
AU  - Oroszi B
AU  - Jancoriene L
AU  - Marin A
AU  - Husa P
AU  - Duffy R
AU  - Dijkstra F
AU  - Gallardo García V
AU  - Goerlitz L
AU  - Enouf V
AU  - Bennett C
AU  - Hooiveld M
AU  - Guiomar R
AU  - Trobajo-Sanmartín C
AU  - Višekruna Vučina V
AU  - Samuelsson Hagey T
AU  - Lameiras Azevedo AS
AU  - Castilla J
AU  - Xuereb G
AU  - Delaere B
AU  - Gómez V
AU  - Tolksdorf K
AU  - Bacci S
AU  - Nicolay N
AU  - Kaczmarek M
AU  - Rose AM
AU  - European IVE group
PY  - 2024
JO  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
DO  - 10.2807/1560-7917.es.2024.29.8.2400089
UR  - https://doi.org/10.2807/1560-7917.es.2024.29.8.2400089
ER  -

APA

M, M., J, H., E, K., F, P., G, P., S, B., N, S., A, M., A, M., AP, R., I, M., I, M., N, L., G, T., M, L., C, M., A, E., S, A., M, B., A, M., R, D., G, P., B, O., L, J., A, M., P, H., R, D., F, D., V, G. G., L, G., V, E., C, B., M, H., R, G., C, T., V, V. V., T, S. H., AS, L. A., J, C., G, X., B, D., V, G., K, T., S, B., N, N., M, K., AM, R., & group, E. I. (2024). Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. https://doi.org/10.2807/1560-7917.es.2024.29.8.2400089

Source records

pubmed · retrieved 2026-09-26T17:21:30.196Z